Tarsus Pharmaceuticals, Inc.
- Last sale
- Nov 12, 2026 · +0.12%
- Market cap
- $3.79B
- 49.31M shares
- Filings
- 679
Q3 2026+146.7% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+93.7% FY25 yoy
- $3.79B
- —
- 5.6×
- 36.4×
- 0.86%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $451,360,000 | reported | |
| FY 2024 | 2024-12-31 | $182,953,000 | reported | |
| FY 2023 | 2023-12-31 | $17,447,000 | reported | |
| FY 2022 | 2022-12-31 | $25,816,000 | reported | |
| FY 2021 | 2021-12-31 | $57,027,000 | reported | |
| FY 2020 | 2020-12-31 | $0 | reported |
Segments
Products
LineFY2025ShareChange
Product sales, net$451.36M100%+150.7%
License fees and collaboration revenue$0.00—−100.0%
Collaboration revenue———
License And Collaboration, Other———
License fees———
License fees and collaboration revenue———
Total$451.36M
Biological products, except diagnostic substances
Tarsus Pharmaceuticals, Inc. is the 16th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
RGENRepligen Corp$738.3M16.4%6.6%$10.7BALVOAlvotech$586.3M19.7%4.8%$1.5BADMAAdma Biologics, Inc.$510.2M19.6%28.8%$2.9BTWSTTwist Bioscience Corp$459.4M22.0%28.3%$7.8B
TARSTarsus Pharmaceuticals, Inc. (this company)$451.4M146.7%14.7%$3.8B
IMCRImmunocore Holdings plc$400.0M29.0%8.9%$1.6BKRYSKrystal Biotech, Inc.$389.1M33.9%52.6%$9.1BADPTAdaptive Biotechnologies Corp$277.0M54.8%21.5%$4.8BVCELVericel Corp$276.3M16.5%6.0%$2.9BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Tarsus Pharmaceuticals, Inc. · CIK 1819790 · Engraved from SEC EDGAR